Molecular Omics

Molecular Omics publishes high-quality research in the -omics sciences. We welcome scientific research based on the application of any -omics technology and we encourage multi-omics approaches to solving important chemical or biological problems. This includes combining different types of omics platforms encompassing genomics, transcriptomics, proteomics, metabolomics and other specialized areas such as glycomics and lipidomics, as well as innovative bioinformatics approaches.

ISSN: 2515-4184

Scope

Molecular Omics publishes high-quality research from across the -omics sciences that provide significant new insight into important chemical or biological problems.

Molecular Omics articles report research that significantly increases understanding or demonstrates clear functional benefits, supported by experimental validation or a novel data analytic approach.

Topics include, but are not limited to:

• omics studies to gain mechanistic insight into biological processes – for example, determining the mode of action of a drug or the basis of a particular phenotype, such as drought tolerance
• omics studies for clinical applications with experimental validation, such as finding biomarkers for diagnostics or potential new drug targets
• omics studies looking at the sub-cellular make-up of cells – for example, the subcellular localisation of certain proteins or post-translational modifications or new imaging techniques
• studies presenting new methods and tools to support omics studies, including new spectroscopic/chromatographic techniques, chip-based/array technologies and new classification/data analysis techniques. New methods should be proven and demonstrate an advance in the field.

The following are not within the scope of Molecular Omics:

• Research based on reanalysis of public datasets without experimental validation and significant omics datasets
• Papers without significant biological justification or interpretation
• Research that is only of interest to the specialist in the area
• Papers reporting new results that could be routinely predicted
• Papers that do not show a significant improvement over known research

Readership

Researchers from industry and academia interested in molecular level research in proteomics, transcriptomics and metabolomics, genomics and other omics science.

Thus the journal will appeal to a wide variety of researchers, but particularly to the following:

• Chemical biologists
• Biological chemists
• Biochemists
• Molecular and structural biologists
• Drug discovery scientists
• Protein chemists
• Bio- and cheminformaticians
• Organic and analytical chemists

Information for authors

Want to publish in this journal? Our author guidelines explain how to prepare and submit your article and provide useful information on the review and publication process including transfers, revisions and any article processing charges (APCs) that may apply.

Read author guidelines

You can read our payments and funding information for further details about APCs, which may apply for publishing open access in this journal, as well available discounts and waivers.

You may be able to publish open access in this journal, with no APC to pay, if your institution has an open access agreement with us. You can use our journal finder tool to check for agreements between us and your institution.